Literature DB >> 15149789

Moderate exercise improves antibody response to influenza immunization in older adults.

Marian L Kohut1, Barbara A Arntson, Wanglok Lee, Kayla Rozeboom, Kyoung-Jin Yoon, Joan E Cunnick, Janet McElhaney.   

Abstract

Influenza vaccine efficacy is reduced among adults over age 65 and a significant number of vaccinated elderly may remain susceptible to influenza virus infection. The effect of moderate exercise training on the immune response to influenza immunization was evaluated in this study. Twenty-seven adults >or=age 64 were assigned to an exercise group (n= 14) or a control group (n = 13). The subjects exercised at 65-75% heart rate reserve (HRR), 25-30 min, 3 days per week, for 10 months. Controls did not change activity. Subjects were immunized with trivalent influenza vaccine before and after the exercise intervention. After the exercise intervention, exercisers exhibited a greater mean fold increase (MFI) in antibody titer to influenza A/New Caledonia/20/99 (H1N1) and A/Panama/2007/99 (H3N2) than controls, and a greater Granzyme B activity to A/Panama/2007/99 than controls. These findings suggest that exercise may enhance the mean fold increase in antibody titer in response to influenza immunization if the influenza antigen was contained in the previous year's vaccine.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15149789     DOI: 10.1016/j.vaccine.2003.11.023

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  43 in total

1.  Vulnerability, distress, and immune response to vaccination in older adults.

Authors:  Suzanne C Segerstrom; Jaime K Hardy; Daniel R Evans; Richard N Greenberg
Journal:  Brain Behav Immun       Date:  2011-10-29       Impact factor: 7.217

2.  Cardiovascular exercise intervention improves the primary antibody response to keyhole limpet hemocyanin (KLH) in previously sedentary older adults.

Authors:  R W Grant; R A Mariani; V J Vieira; M Fleshner; T P Smith; K T Keylock; T W Lowder; E McAuley; L Hu; K Chapman-Novakofski; J A Woods
Journal:  Brain Behav Immun       Date:  2008-03-04       Impact factor: 7.217

3.  Reduced disability and mortality among aging runners: a 21-year longitudinal study.

Authors:  Eliza F Chakravarty; Helen B Hubert; Vijaya B Lingala; James F Fries
Journal:  Arch Intern Med       Date:  2008-08-11

4.  Nutritional and Physical Activity Interventions to Improve Immunity.

Authors:  Glen Davison; Corinna Kehaya; Arwel Wyn Jones
Journal:  Am J Lifestyle Med       Date:  2014-11-25

5.  Immune Function: Impact of Exercise and Nutritional Interventions.

Authors:  Marian L Kohut
Journal:  Am J Lifestyle Med       Date:  2016-02-15

6.  Elderly men with moderate and intense training lifestyle present sustained higher antibody responses to influenza vaccine.

Authors:  Adriana Ladeira de Araújo; Léia Cristina Rodrigues Silva; Juliana Ruiz Fernandes; Manuella de Sousa Toledo Matias; Lucy Santos Boas; Clarisse Martins Machado; Luiz Eugênio Garcez-Leme; Gil Benard
Journal:  Age (Dordr)       Date:  2015-10-19

7.  Age and psychological influences on immune responses to trivalent inactivated influenza vaccine in the meditation or exercise for preventing acute respiratory infection (MEPARI) trial.

Authors:  Mary S Hayney; Christopher L Coe; Daniel Muller; Chidi N Obasi; Uba Backonja; Tola Ewers; Bruce Barrett
Journal:  Hum Vaccin Immunother       Date:  2013-10-07       Impact factor: 3.452

8.  Antibody and CD8+ T cell memory response to influenza A/PR/8/34 infection is reduced in treadmill-exercised mice, yet still protective.

Authors:  Kristi Warren; Nicholas Thompson; Michael Wannemuehler; Marian Kohut
Journal:  J Appl Physiol (1985)       Date:  2013-03-14

9.  Reduced total and cause-specific mortality from walking and running in diabetes.

Authors:  Paul T Williams
Journal:  Med Sci Sports Exerc       Date:  2014       Impact factor: 5.411

10.  Exercise enhances vaccine-induced antigen-specific T cell responses.

Authors:  Connie J Rogers; David A Zaharoff; Kenneth W Hance; Susan N Perkins; Stephen D Hursting; Jeffrey Schlom; John W Greiner
Journal:  Vaccine       Date:  2008-08-14       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.